Third Avenue Management LLC's SUPN Position
Supernus Pharmaceuticals, Inc. — 10 quarters (Q4 2023 to Q4 2025)
Current Shares
189.5K
Current Value
$9.42M
Peak Shares
189.5K
Q3 2024
Overall Change
+19%
Shares Over Time
Q4 2023
159.7K
Q1 2024
159.7K
0%
Q2 2024
189.1K
+18%
Q3 2024
189.5K
0%
Q4 2024
189.5K
0%
Q1 2025
189.5K
0%
Q2 2025
189.5K
0%
Q3 2025
189.5K
0%
Q3 2025
189.5K
0%
Q4 2025
189.5K
0%
Quarterly Detail
| Quarter | Shares | Value | $/Share | Change |
|---|---|---|---|---|
| Q4 2025 | 189.5K | $9.42M | $49.70 | 0% |
| Q3 2025 | 189.5K | $9.10M | $48.04 | 0% |
| Q3 2025 | 189.5K | $9.10M | $48.04 | 0% |
| Q2 2025 | 189.5K | $5.97B | $31520.00 | 0% |
| Q1 2025 | 189.5K | $6.21B | $32750.00 | 0% |
| Q4 2024 | 189.5K | $6.85B | $36160.00 | 0% |
| Q3 2024 | 189.5K | $5.91B | $31180.00 | 0% |
| Q2 2024 | 189.1K | $5.06B | $26750.00 | +18% |
| Q1 2024 | 159.7K | $5.45B | $34110.00 | 0% |
| Q4 2023 | 159.7K | $4.62B | $28940.00 | New |